Published Online:4 Mar 2016https://doi.org/10.1176/appi.ajp.2015.15010093
- Cited by
- 23 November 2023 | GeroScience, Vol. 46, No. 1
- 27 March 2023 | Translational Psychiatry, Vol. 13, No. 1
- Journal of Alzheimer's Disease, Vol. 94, No. 4
- 7 September 2022 | Frontiers in Pharmacology, Vol. 13
- 13 July 2022 | CNS Drugs, Vol. 36, No. 8
- 22 April 2022 | BMJ Open, Vol. 12, No. 4
- 18 January 2022 | Brain Sciences, Vol. 12, No. 2
- 6 April 2021 | Frontiers in Psychiatry, Vol. 12
- Schizophrenia Research, Vol. 222
- Psychiatry Investigation, Vol. 17, No. 7
- 3 February 2020 | Neuropsychopharmacology, Vol. 45, No. 8
- 11 February 2020 | Marine Drugs, Vol. 18, No. 2
- 12 December 2019 | Journal of Psychopharmacology, Vol. 34, No. 1
- 1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 21, No. 3
- 25 October 2018 | npj Schizophrenia, Vol. 4, No. 1
- Philip D. Harvey,
Ph.D.
1 November 2018 | American Journal of Psychiatry, Vol. 175, No. 11- Philip D. Harvey,
- Future Medicinal Chemistry, Vol. 10, No. 4
- Michael Davidson,
M.D. , - Jay Saoud,
Ph.D. , - Corinne Staner,
M.D. , - Nadine Noel,
Ph.D. , - Elisabeth Luthringer,
R.N. , - Sandra Werner,
Ph.D. , - Joseph Reilly,
M.S. , - Jean-Yves Schaffhauser,
Pharm.D. , - Jonathan Rabinowitz,
Ph.D. , - Mark Weiser,
M.D. , - Remy Luthringer,
Ph.D.
28 July 2017 | American Journal of Psychiatry, Vol. 174, No. 12- Michael Davidson,
- European Neuropsychopharmacology, Vol. 27, No. 4
- 15 February 2017 | Journal of Psychopharmacology, Vol. 31, No. 4